Table 4.
Studied groups | Salivary marker |
|
---|---|---|
Salivary TAC (µM) (mean ± SD) | MDA (µM) (mean ± SD) | |
Case girls (n = 20) | 0.66 ± 0.48 | 43.75 ± 66.61 |
Control girls (n = 20) | 0.64 ± 0.71 | 131.15 ± 162.11 |
P | 0.926 | 0.035 |
Case boys (n = 20) | 1.27 ± 2.37 | 60.21 ± 108.01 |
Control boys (n = 20) | 0.97 ± 1.17 | 165.16 ± 188.43 |
P | 0.658 | 0.039 |
Control girls (n = 20) | 0.64 ± 0.71 | 131.15 ± 162.11 |
Control boys (n = 20) | 0.97 ± 1.17 | 165.16 ± 188.43 |
P | 0.299 | 0.544 |
Case girls (n = 20) | 0.66 ± 0.48 | 43.75 ± 66.61 |
Case boys (n = 20) | 1.27 ± 2.73 | 60.21 ± 108.01 |
P | 0.338 | 0.565 |
TAC: Total antioxidant capacity; MDA: Malondialdehyde; SD: Standard deviation